In a recent study, the authors revealed that circIGF2BP3, a novel circRNA, can inhibit the infiltration of CD8+ tumor infiltrating lymphocyte(TIL) and mediate immune evasion in non-small cell lung cancer(NSCLC) [89], which process is correlated with m6A modification. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.